Liu HB - Search Results

1

A novel histone deacetylase inhibitor augments tamoxifen-mediated attenuation of breast carcinoma growth.

Restall C, Doherty J, Liu HB, Genovese R, Paiman L, Byron KA, Anderson RL, Dear AE. Restall C, et al. Among authors: liu hb. Int J Cancer. 2009 Jul 15;125(2):483-7. doi: 10.1002/ijc.24350. Int J Cancer. 2009. PMID: 19330834

2

The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expression.

Liu HB, Voso MT, Gumiero D, Duong J, McKendrick JJ, Dear AE. Liu HB, et al. Int J Oncol. 2009 Feb;34(2):573-9. Int J Oncol. 2009. PMID: 19148494

3

The anti-leukemic effect and molecular mechanisms of novel hydroxamate and benzamide histone deacetylase inhibitors with 5-aza-cytidine.

Liu HB, Mayes PA, Perlmutter P, McKendrick JJ, Dear AE. Liu HB, et al. Int J Oncol. 2011 May;38(5):1421-5. doi: 10.3892/ijo.2011.914. Epub 2011 Jan 20. Int J Oncol. 2011. PMID: 21253674

4

Glucagon-like peptide-1 attenuates tumour necrosis factor-alpha-mediated induction of plasminogen [corrected] activator inhibitor-1 expression.

Liu H, Hu Y, Simpson RW, Dear AE. Liu H, et al. J Endocrinol. 2008 Jan;196(1):57-65. doi: 10.1677/JOE-07-0387. J Endocrinol. 2008. PMID: 18180317

5

A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules.

Liu H, Dear AE, Knudsen LB, Simpson RW. Liu H, et al. J Endocrinol. 2009 Apr;201(1):59-66. doi: 10.1677/JOE-08-0468. Epub 2009 Jan 9. J Endocrinol. 2009. PMID: 19136619

6

Synthesis and biological evaluation of a novel photo-activated histone deacetylase inhibitor.

Sama GR, Liu H, Mountford S, Thompson P, Robinson A, Dear AE. Sama GR, et al. Bioorg Med Chem Lett. 2020 Aug 15;30(16):127291. doi: 10.1016/j.bmcl.2020.127291. Epub 2020 May 30. Bioorg Med Chem Lett. 2020. PMID: 32631513

7

A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.

Vinh A, Gaspari TA, Liu HB, Dousha LF, Widdop RE, Dear AE. Vinh A, et al. Among authors: liu hb. J Vasc Res. 2008;45(2):143-52. doi: 10.1159/000110041. Epub 2007 Oct 24. J Vasc Res. 2008. PMID: 17957103

8

PPARγ-independent thiazolidinedione-mediated inhibition of NUR77 expression in vascular endothelial cells.

Hu Y, Liu HB, Simpson RW, Dear AE. Hu Y, et al. Among authors: liu hb. J Endocrinol. 2011 Jan;208(1):R1-7. doi: 10.1677/JOE-10-0393. Epub 2010 Oct 26. J Endocrinol. 2011. PMID: 20978184

9

A novel agent with histone deacetylase inhibitory activity attenuates neointimal hyperplasia.

Rahmatzadeh M, Liu HB, Krishna SM, Gaspari TA, Welungoda I, Widdop RE, Dear AE. Rahmatzadeh M, et al. Among authors: liu hb. Cardiovasc Drugs Ther. 2014 Oct;28(5):395-406. doi: 10.1007/s10557-014-6540-y. Cardiovasc Drugs Ther. 2014. PMID: 25005755

10

Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies.

Liu HB, Urbanavicius D, Tan P, Spencer A, Dear AE. Liu HB, et al. Int J Oncol. 2014 Oct;45(4):1742-8. doi: 10.3892/ijo.2014.2555. Epub 2014 Jul 22. Int J Oncol. 2014. PMID: 25051119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,011 results

Search Page

Filters